By uncovering the molecules that link amyloid beta with tau hyperphosphorylation, Kam, Park et al.’s results suggest new targets for therapies to treat the symptoms of Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.